The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1

被引：47

作者：

Berkhout, B

Floris, R

Recio, I

Visser, S

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands

[2] NIZO Food Res, Dept Prod Technol, NL-6710 BA Ede, Netherlands

[3] CSIC, Inst Fermentac Ind, E-28006 Madrid, Spain

来源：

BIOMETALS | 2004年 / 17卷 / 03期

关键词：

antiviral protein; HIV-1; lactoferrin; viral entry inhibitor;

D O I：

10.1023/B:BIOM.0000027707.82911.be

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Milk forms a rich source of biologically interesting components and the protein fraction is known to facilitate many different biological functions. In this manuscript, we review the antiviral properties of the milk protein lactoferrin (LF). In particular, we will describe its antiviral activity against the human immunodeficiency virus type 1 (HIV-1).

引用

收藏

页码：291 / 294

页数：4

相关论文

共 48 条

[1] MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO [J].

BABA, M ;

PAUWELS, R ;

BALZARINI, J ;

ARNOUT, J ;

DESMYTER, J ;

DECLERCQ, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6132-6136

[2] Similarity of chemokines charge and the V3 domain of HIV-1 env protein [J].

Berkhout, B ;

Das, AT .

EMERGING INFECTIOUS DISEASES, 1998, 4 (02) :335-336

[3] Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides [J].

Berkhout, B ;

van Wamel, JLB ;

Beljaars, L ;

Meijer, DKF ;

Visser, S ;

Floris, R .

ANTIVIRAL RESEARCH, 2002, 55 (02) :341-355

[4] Structural and functional analysis of negatively charged milk proteins with anti-HIV activity [J].

Berkhout, B ;

Derksen, GCH ;

Back, NKT ;

Klaver, B ;

deKruif, CG ;

Visser, S .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (13) :1101-1107

[5] HIV-1 entry - an expanding portal for drug discovery [J].

Blair, WS ;

Lin, PF ;

Meanwell, NA ;

Wallace, OB .

DRUG DISCOVERY TODAY, 2000, 5 (05) :183-194

[6] Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120 [J].

Cormier, EG ;

Persuh, M ;

Thompson, DAD ;

Lin, SW ;

Sakmar, TP ;

Olson, WC ;

Dragic, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) :5762-5767

[7] Current evidence and future directions for targeting HIV entry - Therapeutic and prophylactic strategies [J].

D'Souza, MP ;

Cairns, JS ;

Plaeger, SF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (02) :215-222

[8] MINIMAL REQUIREMENTS FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 DOMAIN TO SUPPORT THE SYNCYTIUM-INDUCING PHENOTYPE - ANALYSIS BY SINGLE AMINO-ACID SUBSTITUTION [J].

DEJONG, JJ ;

DERONDE, A ;

KEULEN, W ;

TERSMETTE, M ;

GOUDSMIT, J .

JOURNAL OF VIROLOGY, 1992, 66 (11) :6777-6780

[9] A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor [J].

Doranz, BJ ;

GrovitFerbas, K ;

Sharron, MP ;

Mao, SH ;

Goetz, MB ;

Daar, ES ;

Doms, RW ;

OBrien, WA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1395-1400

[10]

Dziuba J, 1999, NAHRUNG, V43, P190, DOI [10.1002/(SICI)1521-3803(19990601)43:3&lt

← 1 2 3 4 5 →